Literature DB >> 15565499

Survival of patients with SLE admitted to an intensive care unit-a retrospective study.

D A Whitelaw1, R Gopal, V Freeman.   

Abstract

We examined the demography, reasons for admission and cause of death in systemic lupus erythematosus (SLE) patients admitted to a medical intensive care unit (ICU) over a 7-year period. Fourteen patients were admitted during this period-all were female, 13 were of mixed ethnic ancestry and one a black South African. Of the 14 patients, 12 were admitted as a result of lupus activity, 2 had sepsis as the major cause of admission, although 5 other patients developed infection during their admission. Five patients had a generalised flare of their disease or progressive renal failure. Seven patients were admitted with a variety of lupus-related pathologies. In general the precise cause of death was difficult to determine. Of the 14 patients, 9 had impaired renal function on admission including 1 with sepsis and 1 of the survivors. Three patients (21%) survived, one with respiratory failure due to shrinking lung, a second with an acute flare of SLE and a third with pulmonary emboli. This study demonstrates that lupus in our community may produce life-threatening flares. Although cause of death was not always definitely identified, admission to the ICU was primarily due to active SLE and not sepsis or iatrogenic disease.

Entities:  

Mesh:

Year:  2004        PMID: 15565499     DOI: 10.1007/s10067-004-1007-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

1.  Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients.

Authors:  B Godeau; E Mortier; P M Roy; S Chevret; G Bouachour; B Schlemmer; J Carlet; J F Dhainaut; C Chastang
Journal:  J Rheumatol       Date:  1997-07       Impact factor: 4.666

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 3.  Systemic lupus erythematosus in the intensive care unit.

Authors:  Rishi Raj; Susan Murin; Richard A Matthay; Herbert P Wiedemann
Journal:  Crit Care Clin       Date:  2002-10       Impact factor: 3.598

4.  Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors.

Authors:  S Studenski; N B Allen; D S Caldwell; J R Rice; R P Polisson
Journal:  Arthritis Rheum       Date:  1987-12

5.  Serum C-reactive protein levels in disease.

Authors:  J J Morley; I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  F M K Williams; S Chinn; G R V Hughes; R M Leach
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

7.  Study of critically ill patients with systemic lupus erythematosus.

Authors:  S M Ansell; S Bedhesi; B Ruff; A G Mahomed; G Richards; M Mer; C Feldman
Journal:  Crit Care Med       Date:  1996-06       Impact factor: 7.598

8.  Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.

Authors:  K M Uramoto; C J Michet; J Thumboo; J Sunku; W M O'Fallon; S E Gabriel
Journal:  Arthritis Rheum       Date:  1999-01

9.  Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail.

Authors:  J M Esdaile; M Abrahamowicz; L Joseph; T MacKenzie; Y Li; D Danoff
Journal:  Arthritis Rheum       Date:  1996-03

10.  Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group.

Authors:  O Nived; G Sturfelt; F Wollheim
Journal:  Q J Med       Date:  1985-06
View more
  7 in total

1.  Outcome of patients with connective tissue disease requiring intensive care for respiratory failure.

Authors:  Jinwoo Lee; Jae-Joon Yim; Seok-Chul Yang; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Eun Young Lee; Eun Bong Lee; Yeong Wook Song; Sang-Min Lee
Journal:  Rheumatol Int       Date:  2011-09-27       Impact factor: 2.631

Review 2.  [Rheumatic patients in the intensive care unit].

Authors:  P Lehmann; T Brünnler; B Salzberger; M Fleck
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02-02       Impact factor: 0.840

3.  Prognostic factors of mortality in Iranian patients with systemic lupus erythematosus admitted to intensive care unit.

Authors:  Alimohammad Fatemi; Somayeh Shamsaee; Ahmad Raeisi; Zahra Sayedbonakdar; Abbas Smiley
Journal:  Clin Rheumatol       Date:  2017-09-06       Impact factor: 2.980

4.  Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide.

Authors:  Kamolwish Laoprasopwattana; Pornsak Dissaneewate; Prayong Vachvanichsanong
Journal:  Pediatr Nephrol       Date:  2009-03-12       Impact factor: 3.714

5.  Epidemiology and outcomes of sepsis among hospitalizations with systemic lupus erythematosus admitted to the ICU: a population-based cohort study.

Authors:  Lavi Oud
Journal:  J Intensive Care       Date:  2020-01-06

6.  The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study.

Authors:  Melanie Sloan; Caroline Gordon; Rupert Harwood; Elliott Lever; Chris Wincup; Michael Bosley; James Brimicombe; Mark Pilling; Stephen Sutton; Lynn Holloway; David D'Cruz
Journal:  Rheumatol Adv Pract       Date:  2020-12-14

7.  Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients.

Authors:  Jin-Min Peng; Bin Du; Qian Wang; Li Weng; Xiao-Yun Hu; Chan-Yuan Wu; Yan Shi
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.